Loading company details...
Beta
Latest Form 4 (Jul 7, 2026): John Spencer (Chief Financial Officer): Grant/Award of 55,900 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 7, 2026 | John Spencer, Chief Financial Officer | Grant/Award | 55,900 | n/a |
| Dec 15, 2025 | Janet Huffman, CEO and CFO | Grant/Award | 250,000 | n/a |
| Dec 15, 2025 | Natasha Giordano | Grant/Award | 38,320 | n/a |
| Dec 15, 2025 | Fred Telling | Sale | 210 | $198.37 |
| Dec 15, 2025 | John P. Gandolfo | Grant/Award | 125,000 | n/a |
| Dec 15, 2025 | Alan W. Dunton | Grant/Award | 125,000 | n/a |
| Dec 15, 2025 | Robert C. Koski | Grant/Award | 125,000 | n/a |
| Dec 15, 2025 | Charles L. Pope | Grant/Award | 125,000 | n/a |
| Jun 18, 2025 | Odyssey Health, Inc. | Sale | 2,000 | $8.9K |
| Jun 16, 2025 | Odyssey Health, Inc. | Sale | 5,000 | $21.3K |